These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The C-terminal region of cellular Qin oligomerizes: correlation with oncogenic transformation and transcriptional repression. Sonderegger CK, Narisawa-Saito M, Vogt PK. Oncogene; 2003 Apr 03; 22(13):1908-15. PubMed ID: 12673196 [Abstract] [Full Text] [Related]
4. Binding of the corepressor TLE1 to Qin enhances Qin-mediated transformation of chicken embryo fibroblasts. Sonderegger CK, Vogt PK. Oncogene; 2003 Mar 27; 22(12):1749-57. PubMed ID: 12660810 [Abstract] [Full Text] [Related]
5. The new serine-threonine kinase, Qik, is a target of the Qin oncogene. Xia Y, Zhang Z, Kruse U, Vogt PK, Li J. Biochem Biophys Res Commun; 2000 Sep 24; 276(2):564-70. PubMed ID: 11027514 [Abstract] [Full Text] [Related]
6. The oncogene qin codes for a transcriptional repressor. Li J, Chang HW, Lai E, Parker EJ, Vogt PK. Cancer Res; 1995 Dec 01; 55(23):5540-4. PubMed ID: 7585630 [Abstract] [Full Text] [Related]
8. Molecular modeling of mutations in the DNA-binding domain of the oncoprotein Qin. Banerjee-Basu S, Baxevanis AD. Mol Cancer Ther; 2002 Nov 24; 1(13):1237-41. PubMed ID: 12479705 [Abstract] [Full Text] [Related]
9. Directed mutation of the basic domain of v-Jun alters DNA binding specificity and abolishes its oncogenic activity in chicken embryo fibroblasts. Basso J, Briggs J, Findlay C, Bos T. Oncogene; 2000 Oct 05; 19(42):4876-85. PubMed ID: 11039905 [Abstract] [Full Text] [Related]
10. Reduced phosphotyrosine binding by the v-Src SH2 domain is compatible with wild-type transformation. Tian M, Martin GS. Oncogene; 1996 Feb 15; 12(4):727-34. PubMed ID: 8632894 [Abstract] [Full Text] [Related]
11. Transformation by the vRel oncoprotein requires sequences carboxy-terminal to the Rel homology domain. Sarkar S, Gilmore TD. Oncogene; 1993 Aug 15; 8(8):2245-52. PubMed ID: 8336947 [Abstract] [Full Text] [Related]
12. Avian cellular homolog of the qin oncogene. Chang HW, Li J, Kretzschmar D, Vogt PK. Proc Natl Acad Sci U S A; 1995 Jan 17; 92(2):447-51. PubMed ID: 7831308 [Abstract] [Full Text] [Related]
13. Differences in kappaB DNA-binding properties of v-Rel and c-Rel are the result of oncogenic mutations in three distinct functional regions of the Rel protein. Nehyba J, Hrdlicková R, Bose HR. Oncogene; 1997 Jun 19; 14(24):2881-97. PubMed ID: 9205096 [Abstract] [Full Text] [Related]
14. Cloning and expression of a chicken c-rel cDNA: unlike p59v-rel, p68c-rel is a cytoplasmic protein in chicken embryo fibroblasts. Capobianco AJ, Simmons DL, Gilmore TD. Oncogene; 1990 Mar 19; 5(3):257-65. PubMed ID: 2179815 [Abstract] [Full Text] [Related]
15. v-Rel and c-Rel are differentially affected by mutations at a consensus protein kinase recognition sequence. Mosialos G, Gilmore TD. Oncogene; 1993 Mar 19; 8(3):721-30. PubMed ID: 8437855 [Abstract] [Full Text] [Related]
16. MafA has strong cell transforming ability but is a weak transactivator. Nishizawa M, Kataoka K, Vogt PK. Oncogene; 2003 Sep 11; 22(39):7882-90. PubMed ID: 12970735 [Abstract] [Full Text] [Related]
17. Oncogenic transformation induced by the Qin protein is correlated with transcriptional repression. Li J, Thurm H, Chang HW, Iacovoni JS, Vogt PK. Proc Natl Acad Sci U S A; 1997 Sep 30; 94(20):10885-8. PubMed ID: 9380729 [Abstract] [Full Text] [Related]
18. Mutational analysis of the role of the carboxy-terminal region of the v-erbB protein in erythroid cell transformation. Lee EB, Beug H, Hayman MJ. Oncogene; 1993 May 30; 8(5):1317-27. PubMed ID: 8097581 [Abstract] [Full Text] [Related]